Blandine Cherifi-Gatta

Team: Energy balance and obesity
Professor - Hospital practitioner  |  MD-PhD (PU PH)  |  Université de Bordeaux / CHU


Publications

Quantitative MRI biomarkers measure changes in targeted brain areas in patients with obesity.
Louise Baynat, Takayuki Yamamoto, Thomas Tourdias, Bei Zhang, Valentin Prevost, Asael Infante, Achille Klein, Julien Caid, Olivier Cadart, Vincent Dousset, Blandine Gatta Cherifi
The Journal of Clinical Endocrinology & Metabolism. 2024-01-09

10.1210/clinem/dgae014

Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample
Sophie-Athéna Chapron, Charlotte Kervran, Marco Da Rosa, Lucie Fournet, Dvora Shmulewitz, Deborah Hasin, Cécile Denis, Julie Collombat, Maude Monsaingeon, Mélina Fatseas, Blandine Gatta-Cherifi, Fuschia Serre, Marc Auriacombe
Drug and Alcohol Dependence. 2023-10-01

10.1016/j.drugalcdep.2023.110937

Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
Mathijs Drummen, Lea Tischmann, Blandine Gatta-Cherifi, Daniela Cota, Isabelle Matias, Anne Raben, Tanja Adam, Margriet Westerterp-Plantenga
The Journal of Clinical Endocrinology & Metabolism. 2020-04-25

10.1210/clinem/dgaa193

Étude des interactions entre le système endocannabinoïde et la pathologie de l’axe corticotrope chez l’Homme
F. Verdier, A. Ferrière, M. Haïssaguerre, J. Teynié, P. Perez, R. Sitta, D. Cota, I. Matias, B. Gatta-Cherifi, A. Tabarin
Annales d'Endocrinologie. 2018-09-01

10.1016/j.ando.2018.06.271

P2101 Effet d’un régime hypoglucidique sur le métabolisme et les concentrations plasmatiques des endocannabinoïdes chez des patients diabétiques de type 2
B. Gatta Cherifi, E. Maury, I. Belluomo, M. Isabelle, I. Matias, A. Tabarin, D. Cota, V. Rigalleau
Diabetes & Metabolism. 2013-03-01

10.1016/s1262-3636(13)72011-1

Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity
Isabelle Matias, Blandine Gatta-Cherifi, Daniela Cota
Curr Obes Rep. 2012-08-17

10.1007/s13679-012-0027-6

Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
B Gatta-Cherifi, I Matias, M Vallée, A Tabarin, G Marsicano, P V Piazza, D Cota
Int J Obes Relat Metab Disord. 2011-08-16

10.1038/ijo.2011.165

    • Contact
    • Neurocentre Magendie - INSERM U 1215 - 146, rue Léo Saignat - 33077 Bordeaux
    • +33 5 57 65 62 35